In this video interview, Del Smith, PhD, CEO and co-founder of Acclinate, examines the structural and relational barriers ...
In part 1 of this three-part series, behavioral science reveals how slow patient recruitment and enrollment challenges often ...
Thermo Fisher Scientific has completed its acquisition of Clario Holdings for $8.875 billion in cash, plus potential ...
ACT Brief: Thermo Fisher Acquires Clario, Wearables and AI Integration, and Somatic Genomics for IBD
In today's ACT Brief, we examine Thermo Fisher's acquisition of Clario to expand clinical trial data infrastructure, how ...
In this Q&A, Mohammed Saeed, MD, PhD, chief medical officer at Solera Health, explores how wearable devices and continuous remote monitoring are reshaping clinical oversight, from early intervention ...
In today's ACT Brief, we explore how AI can parse wearable data streams to identify subtle clinical patterns, FDA's four ...
Early 2026 has brought a series of consequential regulatory moves from the FDA, each reflecting a common thread: the agency ...
In this video interview, Mohammed Saeed, MD, PhD, chief medical officer of Solera Health, explores how AI models capable of ...
In today's ACT Brief, we explore how FDA clearance and reimbursement models support wearable adoption in clinical care, the importance of end-to-end data validation before patient enrollment, and FDA ...
Ultimately, the data and technology systems validation capability can become a strategic differentiator that enables faster ...
In this video interview, Mohammed Saeed, MD, PhD, chief medical officer of Solera Health, discusses how regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results